Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 1641402, 6 pages
Research Article

Mesenchymal Stem Cell Treatment for Steroid Refractory Graft-versus-Host Disease in Children: A Pilot and First Study from Turkey

1Department of Pediatric Hematology/Oncology & Bone Marrow Transplantation Unit, Faculty of Medicine, Acıbadem University, Atakent Hospital, 34303 Istanbul, Turkey
2Acıbadem University, Acıbadem Labcell, 34303 Istanbul, Turkey

Received 15 July 2015; Accepted 10 August 2015

Academic Editor: Thomas Ichim

Copyright © 2016 Fatih Erbey et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [4 citations]

The following is the list of published articles that have cited the current article.

  • Yuho Najima, and Kazuteru Ohashi, “Mesenchymal Stem Cells: The First Approved Stem Cell Drug in Japan,” Journal of Hematopoietic Cell Transplantation, vol. 6, no. 3, pp. 125–132, 2017. View at Publisher · View at Google Scholar
  • Amara Seng, and Neil Dunavin, “Mesenchymal stromal cell infusions for acute graft-versus-host disease: Rationale, data, and unanswered questions,” Advances in Cell and Gene Therapy, pp. e14, 2018. View at Publisher · View at Google Scholar
  • Shihua Wang, Rongjia Zhu, Hongling Li, Jing Li, Qin Han, and Robert Chunhua Zhao, “Mesenchymal stem cells and immune disorders: from basic science to clinical transition,” Frontiers of Medicine, 2018. View at Publisher · View at Google Scholar
  • Fatih Erbey, Arzu Akçay, Didem Atay, Ercüment Ovalı, and Gülyüz Öztürk, “Comparison of outcomes after HLA-matched unrelated and αβ T-cell-depleted haploidentical hematopoietic stem cell transplantation for children with high-risk acute leukemia,” Pediatric Transplantation, pp. e13192, 2018. View at Publisher · View at Google Scholar